-65.7%
MRNA vs ENPH
-77.1%
+11.4%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ENPH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.4% | +6.8% | +5.8% |
| 7D | -1.1% | -0.1% | -1.0% | -1.2% |
| 30D | +126.1% | -10.8% | +137.0% | +134.5% |
| 3M | +190.0% | -33.8% | +223.9% | +220.6% |
| 6M | +157.2% | -16.1% | +173.4% | +159.4% |
| YTD | +388.2% | +13.4% | +374.8% | +339.5% |
| 1Y | +467.0% | -2.6% | +469.6% | +428.4% |
| 3Y | +36.1% | -70.3% | +106.3% | +62.4% |
| All | -65.7% | -77.1% | +11.4% | -61.1% |
Cumulative growth
Daily Returns
Daily percentage return beside ENPH.
Daily Out/Under-Performance
Portfolio return minus ENPH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENPH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ENPH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling